Blood thinner choices for people with atrial fibrillation and heart disease
Treatments studied
Part of Heart & circulation clinical trials.
This study compares two blood-thinning medicines to see which works better for people who have both atrial fibrillation (irregular heartbeat) and heart disease. It aims to reduce the risk of heart attack or stroke while avoiding bleeding problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older, but not over 85.
- You have atrial fibrillation and a stroke risk score of 2 or higher.
- You have stable heart disease, such as a past stent or bypass surgery, or narrowed heart arteries confirmed by a test.
- You have an extra risk factor for heart attack, like a past heart attack, complex stent procedure, or narrowed arteries in your legs or brain.
- You have not had a stent or bypass in the last 6 months, and no heart attack in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This study compares two strategies for managing atrial fibrillation (irregular heartbeat) in people on dialysis: one uses a blood thinner called apixaban to prevent strokes, and the other does not. The goal is to find out which approach is safer and more effective for this specific group.
This study tests whether a common blood thinner (apixaban) alone is as safe and effective as combining it with another drug (clopidogrel) to prevent future strokes in people who have both atrial fibrillation and narrowing in the arteries leading to the brain. It aims to find the best way to reduce stroke risk while minimizing bleeding.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This study tests how well anticoagulant medicines dissolve blood clots in the heart of people with atrial fibrillation. It may help doctors choose the best treatment to prevent strokes.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.